Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aion Therapeutic Inc ANTCF


Primary Symbol: C.AION

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Comment by gainwidpatienceon Feb 14, 2021 10:51am
111 Views
Post# 32564439

RE:RE:RE:$1+ stock of future!

RE:RE:RE:$1+ stock of future!

There are many companies in psychedelic space have good market capitalization without any progress!

Talking about Aion.. way undervalued! Merely 13m market capitalization.. they have 5 patents filed already. These guyz are targeting 100B market! Dr. Stephen Barnhill came out from his retirement to do something big in this space! Read about PCAI and Stephen Barnhill from the below link.


These pharmaceutical, nutraceutical and cosmeceutical products will be developed leveraging the most healing chemical compounds from medical cannabis in combination with chemical compounds from psychedelic and edible mushrooms with a goal to successfully treat conditions like cancer, depression, PTSD and others, as well as opioid and alcohol addiction. 

Ultimately, PCAI is focusing on the next wave of science and therapeutics for this $100B annual total addressable market. 


https://www.pcai.ca/about
 

<< Previous
Bullboard Posts
Next >>